Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The evidence suggests that if you tolerate either form well and follow dosing instructions precisely, you can expect comparable metabolic benefits
Fahrmann JF, Schmidt CM, Mao X, Irajizad E, Loftus M, Zhang J, Patel N, Vykoukal J, Dennison JB, Long JP et al
These questions are known as your Recovery Tracker
FDA Approved: Yes (First approved November 8, 2023) Brand name: Zepbound Generic name: tirzepatide Dosage form: Injection Company: Eli Lilly and Company Treatment for: Weight Loss, Obstructive Sleep Apnea/Hypopnea Syndrome Add Drugs.com on Google Zepbound (tirzepatide) is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for weight reduction in adults with obesity or adults with overweight, and severe obstructive sleep apnea in adults with obesity
US$ 22.47
US$ 25.66
US$ 25.36
